Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Worldwide Consumer Health Sales Jump 13%

This article was originally published in The Tan Sheet

Executive Summary

Foreign sales gains in the Bufferin analgesic line - most notably in Japan - helped Bristol-Myers Squibb's worldwide consumer drug sales see a 13% increase to $274 mil. in the second quarter, the company reported July 20. Excluding foreign exchange, the segment's revenues jumped 17%.

You may also be interested in...



BMS Streamlining To Focus On Consumer Medicines, Nutritionals

Bristol-Myers Squibb's decision to divest its Clairol cosmetics and Zimmer orthopedic implants businesses in the next 6 to 12 months is part of the company's strategy to focus its resources on its core medicines segments.

BMS Streamlining To Focus On Consumer Medicines, Nutritionals

Bristol-Myers Squibb's decision to divest its Clairol cosmetics and Zimmer orthopedic implants businesses in the next 6 to 12 months is part of the company's strategy to focus its resources on its core medicines segments.

BMS Streamlining To Focus On Consumer Medicines, Nutritionals

Bristol-Myers Squibb's decision to divest its Clairol cosmetics and Zimmer orthopedic implants businesses in the next 6 to 12 months is part of the company's strategy to focus its resources on its core medicines segments.

Related Content

Topics

UsernamePublicRestriction

Register

PS091452

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel